Human T Cell Leukemia Virus (htlv) - Infectious Diseases

Relevant Publications

Imbalanced IL10/TGF-β production by regulatory T-lymphocytes in patients with HTLV-1-associated myelopathy/ tropical spastic paraparesis.

Issue Release: 2024

Trans-Activation of the () Gene by the Oncogene Product Tax of Human T-Cell Leukemia Virus Type 1.

Issue Release: 2024

HTLV-1 vaccination Landscape: Current developments and challenges.

Issue Release: 2024

Lived Experience of Human T-cell Leukemia Virus type-1 -Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP): A Phenomenology Study.

Issue Release: 2024

Novel paired CD13-negative (MT-50.1) and CD13-positive (MT-50.4) HTLV-1-infected T-cell lines with differential regulatory T cell-like activity.

Issue Release: 2024

Modified Prophylactic Donor Lymphocyte Infusion (DLI) in an Adult T Cell Lymphoma/Leukemia (ATLL) Patient-Modality of Relapse Prevention.

Issue Release: 2024

Effects of HTLV-1 on leukocyte trafficking and migration in ACs compared to healthy individuals.

Issue Release: 2024

Distinct stabilization of the human T cell leukemia virus type 1 immature Gag lattice.

Issue Release: 2024

Novel approaches for HTLV-1 therapy: innovative applications of CRISPR-Cas9.

Issue Release: 2024

Global transcriptomic network analysis of the crosstalk between microbiota and cancer-related cells in the oral-gut-lung axis.

Issue Release: 2024

Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy.

Issue Release: 2024

Comprehensive Insight into the Functional Roles of NK and NKT Cells in HTLV-1-Associated Diseases and Asymptomatic Carriers.

Issue Release: 2024

Purification Method of Extracellular Vesicles Derived from Human T-Cell Leukemia Virus Type 1-Infected Cells without Virions.

Issue Release: 2024

How do socioeconomic determinants of health affect the likelihood of living with HTLV-1 globally? A systematic review with meta-analysis.

Issue Release: 2024

HTLV-1 Tax Tug-of-War: Cellular Senescence and Death or Cellular Transformation.

Issue Release: 2024

IMiD/CELMoD-induced growth suppression of adult T-cell leukemia/lymphoma cells cereblon through downregulation of target proteins and their downstream effectors.

Issue Release: 2024

HTLV-1 induces an inflammatory CD4+CD8+ T cell population in HTLV-1-associated myelopathy.

Issue Release: 2024

Role of Interleukin-17 cytokine family in human T-cell lymphotropic virus type 1 (HTLV-1) infection and associated diseases.

Issue Release: 2024

Therapeutic advances for the management of adult T cell leukemia: Where do we stand?

Issue Release: 2024

Analysis of the Main Checkpoints of the JNK-MAPK Pathway in HTLV-1-Associated Leukemia/Lymphoma via Boolean Network Simulation.

Issue Release: 2024

What Are the Common Concerns About Vaccines?

What are Influenza Antivirals?

How Can Schools and Universities Incorporate Infectious Disease Education?

Which Infectious Diseases Are Common Culprits?

Can Yellow Fever be Prevented?

What Role Do Vaccines Play?

What are the Challenges in Disease Eradication?

How Can We Promote Condom Use?

How is HSV Transmitted?

What Are Vector-Borne Diseases and How Are They Affected?

Partnered Content Networks

Relevant Topics